Largest Insider Trades of the Week

In this article:

- By Tiziano Frateschi

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to "$200,000+," the duration to "September 2018" and All Insider Sales to "$5,000,000+."


According to the above filters, the following are trades from company insiders this week.

Tyagi Ashu, director of Y-mAbs Therapeutics Inc. (YMAB), bought 430,174 shares for an average price of $16 per share on Sept. 25.

1538166799019.png
1538166799019.png

The clinical-stage biopharmaceutical company has a market cap of $911 million. It has an insider ownership of 3.45%.

Over the last 12 months, the stock has gained 11%.

Redmile Group LLC, director and 10% owner of Fate Therapeutics Inc. (FATE), bought 3,703,704 shares for an average price of $13.50 per share on Sept. 25.

1538166130673.png
1538166130673.png

The biotechnology company has a market cap of $870 million and an enterprise value of $807 million. It has an institutional ownership of 74.39% and insider ownership of 1.16%.

Over the last 12 months, the stock has climbed 300% and, as of Friday, is 2.16% below its 52-week high and 365% above its 52-week low.

Richard D. Kinder, executive chairman and 10% owner of Kinder Morgan Inc. (KMI), bought 500,000 shares for an average price of $17.55 per share on Sept. 27.

1538166748435.png
1538166748435.png

The energy infrastructure company has a market cap of $39 billion and an enterprise value of $77 billion. The company has an institutional ownership of 56% and insider ownership of 12.80%.

Over the last 12 months, the stock has declined 8% and is currently 8.18% below its 52-week high and 20.69% above its 52-week low.

Most important insider sales

Joseph S. Zakrzewski, director, Joseph T. Kennedy, general counsel, and Steven B. Ketchum, chief shientific officer of Amarin Corp. PLC (AMRN) sold a combined 2,458,947 shares for an average price of $10.75 per share on Sept. 24 and Sept. 25.

1538166399560.png
1538166399560.png

The biopharmaceutical company has a $4.76 billion market cap and an enterprise value of $4.8 billion. It has an institutional ownership of 36.16% and insider ownership of 0.73%.

Over the last 12 months, the stock has risen 29% and is currently 1.91% below its 52-week high and 51.50% above its 52-week low.

Mak Capital One LLC and Centerbridge Capital Partners, 10% owners of Skyline Champion Corp. (SKY), sold a combined 7,452,008 shares for an average price of $27.93 per share on Sept. 25.

1538166550025.png
1538166550025.png

The home builder has a market cap of $1.61 billion and an enterprise value of $1.59 billion. It has an institutional ownership of 78.61% and insider ownership of 50.34%.

Over the last 12 months, the stock has gained 138% and is currently 19.86% below its 52-week high and 177% above its 52-week low.

NBL Midstream LLC, 10% owner of CNX Midstream Partners LP (CNXM), sold 14,217,198 shares for an average price of $17.75 per share on Sept. 27.

1538166629089.png
1538166629089.png

The midstream oil and gas company has a market cap of $1.23 billion and an enterprise value of $1.7 billion. It has an institutional ownership of 53.46% and insider ownership of 0.19%.

Over the last 12 months, the stock price has climbed 19% and is currently 8.55% below its 52-week high and 26.23% above its 52-week low.

Disclosure: I do not own any stocks mentioned in this article.

This article first appeared on GuruFocus.


Advertisement